Association between polysomnographic measures of disrupted sleep and prothrombotic factors

Chest

Volumn 131, Issue 3, 2007, Pages 733-739

  Von Känel, Roland ^a   Loredo, José S ^c   Ancoli Israel, Sonia ^b   Mills, Paul J ^b   Natarajan, Loki ^d   Dimsdale, Joel E ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apnea; Cardiovascular disease; Hemostasis; Sleep

Indexed keywords

D DIMER; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOPLASTIN; VON WILLEBRAND FACTOR;

ADULT; AGE; APNEA; AROUSAL; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DEVICE; ETHNICITY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP DISORDER; SMOKING; STATISTICAL ANALYSIS;

EID: 33947375205     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-2006     Document Type: Article

References (38)

1. Shah K. Thrombogenic risk factors for atherothrombosis. Rev Cardiovasc Med 2006; 7:10-16
2. Kannel WB. Overview of hemostatic factors involved in atherosclerotic cardiovascular disease. Lipids 2005; 40:1215-1220
3. Saigo M, Hsue PY, Waters DD. Role of thrombotic and fibrinolytic factors in acute coronary syndromes. Prog Cardiovasc Dis 2004; 46:524-538
4. Folsom AR. Hemostatic risk factors for atherothrombotic disease: an epidemiologic view. Thromb Haemost 2001; 86:366-373
5. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163:19-25
6. Mooe T, Franklin KA, Holmstrom K, et al. Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med 2001; 164:1910-1913
7. Peker Y, Hedner J, Kraiczi H, et al. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000; 162:81-86
8. Vitaliano PP, Scanlan JM, Zhang J, et al. A path model of chronic stress, the metabolic syndrome, and coronary heart disease. Psychosom Med 2002; 64:418-435
9. Mausbach BT, Patterson TL, Rabinowitz Y, et al. Depression and distress predict time to cardiovascular disease in dementia caregivers. Health Psychology 2007 (in press)
10. Wessendorf TE, Thilmann AF, Wang YM, et al. Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med 2000; 162:2039-2042
11. Nobili L, Schiavi G, Bozano E, et al. Morning increase of whole blood viscosity in obstructive sleep apnea syndrome. Clin Hemorheol Microcirc 2000; 22:21-27
12. Reinhart WH, Oswald J, Walter R, et al. Blood viscosity and platelet function in patients with obstructive sleep apnea syndrome treated with nasal continuous positive airway pressure. Clin Hemorheol Microcirc 2002; 27:201-207
13. Robinson GV, Pepperell JC, Segal HC, et al. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 2004; 59:777-782
14. Geiser T, Buck F, Meyer BJ, et al. In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration 2002; 69:229-234
15. Hui DS, Ko FW, Fok JP, et al. The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. Chest 2004; 125:1768-1775
16. Rangemark C, Hedner JA, Carlson JT, et al. Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients. Sleep 1995; 18:188-194
17. von Känel R, Loredo JS, Ancoli-Israel S, et al. Association between sleep apnea severity and blood coagulability: treatment effects of nasal continuous positive airway pressure. Sleep Breath 2006; 10:139-146
18. von Känel R, Dimsdale JE, Ancoli-Israel S, et al. Poor sleep is associated with higher plasma proinflammatory cytokine interleukin-6 and procoagulant marker fibrin D-dimer in older caregivers of people with Alzheimer's disease. J Am Geriatr Soc 2006; 54:431-437
19. von Känel R, Dimsdale JE. Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease. Chest 2003; 124:1956-1967
20. Schwartz S, McDowell Anderson W, Cole SR, et al. Insomnia and heart disease: a review of epidemiologic studies. J Psychosom Res 1999; 47:313-333
21. Wolk R, Gami AS, Garcia-Touchard A, et al. Sleep and cardiovascular disease. Curr Probl Cardiol 2005; 30:625-662
22. Makin AJ, Blann AD, Chung NA, et al. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells: relationship with von Willebrand factor and tissue factor. Eur Heart J 2004; 25:371-376
23. Meyer D, Girma JP. von Willebrand factor: structure and function. Thromb Haemost 1993; 70:99-104
24. Falciani M, Gori AM, Fedi S, et al. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients. Thromb Haemost 1998; 79:495-499
25. Lip GY, Lowe GD. Fibrin D-dimer: a useful clinical marker of thrombogenesis? Clin Sci 1995; 89:205-214
26. Kohler HP, Grant PJ. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 2000; 342:1792-1801
27. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350:1387-1397
28. Danesh J, Whincup P, Walker M, et al. Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis. Circulation 2001; 103:2323-2327
29. Jude B, Zawadzki C, Susen S, et al. Relevance of tissue factor in cardiovascular disease. Arch Mal Coeur Vaiss 2005; 98:667-671
30. Loredo JS, Nelesen R, Ancoli-Israel S, et al. Sleep quality and blood pressure dipping in normal adults. Sleep 2004; 27:1097-1103
31. Thomas KS, Nelesen RA, Ziegler MG, et al. Job strain, ethnicity, and sympathetic nervous system activity. Hypertension 2004; 44:891-896
32. Metropolitan Life Foundation. Metropolitan height and weight tables. Stat Bull Metropolitan Insur Co 1983; 64:1
33. ASDA report: EEG arousals; scoring rules and examples. Sleep 1992; 15:174-184
34. Rechtshaffen A, Kales A. A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. Washington, DC: US Government Printing Office, 1968; publication No. 204
35. Mallon L, Broman JE, Hetta J. Sleep complaints predict coronary artery disease mortality in males: a 12-year follow-up study of a middle-aged Swedish population. J Intern Med 2002; 251:207-216
36. Venugopal B, Sharon R, Abramovitz R, et al. Plasminogen activator inhibitor-1 in cardiovascular cells: rapid induction after injecting mice with kainate or adrenergic agents. Cardiovasc Res 2001; 49:476-483
37. Mills PJ, Kennedy BP, Loredo JS, et al. Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive sleep apnea. J Appl Physiol 2006; 100:343-348
38. von Känel R, Dimsdale E. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 2000; 65:357-369